$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
All You Need to Know About VAXART, INC. (VXRT) Rating Upgrade to Buy
01:07pm, Monday, 07'th Feb 2022
VAXART, INC. (VXRT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does Vaxart's Oral COVID Vaccine Have a Chance?
11:55am, Saturday, 29'th Jan 2022 The Motley Fool
The short answer -- yes.
Does Vaxart''s Oral COVID Vaccine Have a Chance?
11:55am, Saturday, 29'th Jan 2022 The Motley Fool
The short answer -- yes.
4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall Street
10:51am, Saturday, 29'th Jan 2022 The Motley Fool
Select analysts and investment banks believe these little-known companies can skyrocket.
Does Vaxart's Oral COVID Vaccine Have a Chance?
06:55am, Saturday, 29'th Jan 2022
The short answer -- yes.
4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall Street
05:51am, Saturday, 29'th Jan 2022
Select analysts and investment banks believe these little-known companies can skyrocket.
Could Vaxart's Vaccine Pill Help to End the Pandemic?
11:33am, Thursday, 27'th Jan 2022 The Motley Fool
Probably not, but it sure might help.
4 of the Fastest-Growing Stocks on the Planet in 2022
10:36am, Thursday, 27'th Jan 2022 The Motley Fool
This diverse mix of companies is expected to deliver revenue growth of 236% to 5,460% this year.
Could Vaxart's Vaccine Pill Help to End the Pandemic?
06:33am, Thursday, 27'th Jan 2022
Probably not, but it sure might help.
Novel Preventative Solutions Seek to Curtail the Spread of the Pandemic
02:00pm, Wednesday, 19'th Jan 2022 Benzinga
NEW YORK , Jan. 19, 2022 /PRNewswire/ -- The number of people infected by the Omicron variant of COVID-19 has broken records since the new year had started. As a result of the new wave, testing kits are in short supply. According to Anthony S. Fauci , Chief Medical Adviser to President Biden, it is going to be very important "that we get a greater capability of testing, particularly when the demand for testing is so high, with the combination of the Omicron variant itself, as well as the holiday season, where people want to get that extra level of assuredness that they''re protected, even if you are vaccinated and boosted." This week, the government responded by launching a website where Americans can request a free, at-home COVID-19 test. Todos Medical Ltd. (OTC: TOMDF ), Moderna, Inc. (NASDAQ: MRNA ), Pfizer Inc. (NYSE: PFE ), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Vaxart, Inc. (NASDAQ: VXRT ) In the meantime, in New York , which is once again the epicenter of the pandemic in the U.S., it was announced that city officials are negotiating a temporary return to remote learning for tens of thousands of students who aren''t showing up for class. "The real analysis that shows we were on the right path.
Which Vaccine Stocks Will Make You a Fortune in 2022?
11:15am, Wednesday, 12'th Jan 2022 The Motley Fool
It's not too late to invest in this dynamic area.
Which Vaccine Stocks Will Make You a Fortune in 2022?
06:15am, Wednesday, 12'th Jan 2022
It's not too late to invest in this dynamic area.
Is This Vaccine Stock a Buy?
12:55pm, Monday, 10'th Jan 2022 The Motley Fool
This biotechnology company has a nifty trick up its sleeve.
Is This Vaccine Stock a Buy?
07:55am, Monday, 10'th Jan 2022
This biotechnology company has a nifty trick up its sleeve.
Vaxart: Oral Covid-19 Vaccine Is Interesting, But Questions Linger
06:00am, Monday, 10'th Jan 2022
VXRT stock is more than a Covid-19 meme trade. But is there enough fundamentals there to support an investment heading into 2022?
Sign In
Buy VXRT